|
參考文獻 Arnold W.P., Mittal C.K., Katsuki S., Murad F. (1997): Nitric oxide activates guanylyl cyclase and increases guanosine 3’,5’-monophosphate levels in various tissue preparations. Proc Natl Acad Sci. 74:3203-3207 Beavo J.A. (1995): Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 75:725-748 Becker E.B., Schmidt P., Schramm M., Schröder H., Hoencka M., Gerzer R., Stasch J.P. (2000): The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets. J Cardio Pharmacol. 35:390-397 Böhme E., Graf H., Schultz G. (1978): Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res. 9:131-143 Chiou W.F., Chou C.J., Shum A.Y., Chen C.F. (1992): The vasorelavant effects of evodiamine in rat isolated mesenteric arteries. Eur J Pharmacol. 215:277-283 Chiou W.F., Chen J., Chen C.C. (1998): Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit. Br J Pharmacol. 125:1677-1684 Chirkov Y.Y., Holmes A.S., Chirkova L.P., Horowitz J.D. (1999): Nitrate resistance in platelet from patients with stable angina pectoris. Circulation 100:129-134 Choi Y.D., Chung W.S., Choi H.K. (1999): The action mechanism of relaxation effect of atropine on the isolated rabbit corpus cavernosum. J Urol. 161:1976-1979 Cortijo J., Beleta J., Cardelus I., Llenas J., Morcillo E., Gristwood R.W. (1993): Investigation into the role of phosphodiesterase IV in brochrelaxation, including studies with human bronchus. Br J Pharmacol. 108:562-568 Delpy E., Coste H., Gouville A.C. (1996): Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br J Pharmacol. 119:471-478 Feleder E.C., Adler-Graschinsy E. (1997): Endothelium-mediated and Nw-nitro-L-arginine methyl ester-sensitive responses to cromakalim and diazoxide in the rat mesenteric bed. Eur J Pharmacol. 319:229-238 Freedman J.E., Ting B., Hankin B., Loscalzo J., Keaney J.J., Vita J.A. (1998): Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation 98:1481-1486 Filippi S., Amerini S., Maggi M., Natali A., Ledda F. (1999): Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol. 161:326-331 Friebe A., Mullershausen F., Smolenski A., Walter U., Schultz G., Koesling D. (1998): YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol. 54:962-967 George W.J., Polson J.B., O’Toole A.G., Goldberg N.D. (1970): Elevation of cGMP in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci. 66:398-403 Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. (1998): Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 338:1397-1404 Hayashida H., Okamura T., Tomoyoshi T., Toda N. (1996): Neurogenic nitric oxide mediates relaxation of canine corpus cavernosum. J Urol. 155:1122-1127 Hidaka H., Asano T. (1976): Human blood platelet 3,: 5,-cyclic nucleotide phosphodiesterase. Isolation of low Km and high Km phosphodiesterase. Biochem Biophy Acta. 429:485-497 Ignarro L.J. (1990): Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 30:535-560 Kim Y.C., Kim J.H., Davies M.G., Hagen P.O., Carson C.C. (1995): Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum. J Urol. 153:807-10 Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., Teng C.M. (1994): YC-1, a novel activator of platelet guanylate cyclase. Blood 84:4226-4233 Kubo M., Nakaya Y., Matsuoka S., Saito K., Kuroda Y. (1993): Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle. Circ Res. 74:471-476 Lin R.J., Wu B.N., Lo Y.C., Shen K.P., Lin Y.T., Huang C.H., Chen I. J. (2002): KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K+ channels. Br J Pharmacol. 1159-1166 Lowenstein C.J., Dinerman J.L., Snyder S.H. (1994): Nitric oxide: A physiology messenger. Ann Intern Med. 120:227-237 Moncada S., Palmer R.M., Higgs E.A. (1991): Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:109-142 Nehra A., Barrett D.M., Moreland R.B. (1999): Pharmacotherapeutic advances in the treatment of erectile dysfunction. Clin Proc. 74:709-721 Nicholsen C.D., Chaliss R.A., Shalid M. (1991): Differential modulation of tissue function and therapeutic potential of selective inhibitor of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 12:19-27 Pe’rez-Vizcaino F., Cogolluddo A.L., Villamor E., Tamargo J. (1998): Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways. Br J Pharmacol. 128:847-854 Puri R.N. (1999): ADP-induced platelet aggregation and inhibition of adenylyl cyclase activity stimulated by prostaglandins: signal transduction mechanisms. Biochem Pharmacol. 57:851-859 Schafer A.I. (1996): Antiplatelet therapy. Am J Med. 101:199-209 Schmidt H.H., Lohmann S.M., Walter U. (1993): The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta. 1178:153-175 Sobey C. G. (2001): Potassium channels function in vascular disease. Arterioscler Throm Vasc Bio. 21:28-38 Kitazono T., Faraci F.M., Taguchi H., Heistad D. D. (1995): Role of Potassium Channels in Cerebral Blood Vessels. Stroke 26:1713-1723 White R., Hiley C.R. (1998): Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery. Br J Pharmacol. 124:1219-1226 Wohlfart P., Malinski T., Ruetten H., Schindler U., Linz W., Schoenafinger K., Strobel H., Wiemer G. (1999): Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol. 128:1316-1322 Wu B.N., Lin R.J., Lin C.Y., Shen K.P., Chiang L.C., Chen I. J. (2001): A xanthine-based KMUP-1 with cyclic GMP enhancing and K+ channels opening activities in rat aortic smooth muscle. Br J Pharmacol. 134:265-274 Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.M. (1995): YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol. 116:1973-1978 Wu C.C., Ko F.N., Teng C.M. (1997): Inibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem Biophys Res Commun. 231:412-416
|